Receptor-activated and energy-dependent decrease of muscarinic cholinergic receptors in guinea-pig vas deferens

Agonist-induced muscarinic cholinergic receptor internalization, recycling and degradation in cultured neuronal cells. Cellular mechanisms and role in desensitization

Short-term incubation of intact neuronal cells with muscarinic cholinergic agonists resulted in a rapid decrease of the specific binding of [3H]methylscopolamine to cell surface receptors indicative of receptor internalization. The agonists induced the internalization of both the muscarinic receptor subtypes coupled to adenylyl cyclase and those coupled to phosphoinositide turnover. Receptor internalization, which was inhibited at 0-4 degrees and by depletion of intracellular K+, is thought to occur through coated pits formation and was rapidly reversible. Receptor recycling did not imply protein synthesis. Down-regulation of muscarinic receptors occurred slowly in the presence of agonists, needed intact cytoskeleton (demonstrated by the inhibitory effect of colchicine) and involved lysosomal activity. Both receptor internalization and down-regulation were prevented by muscarinic receptor antagonists. Receptor internalization and down-regulation are agonist-induced cellular mechanisms that with receptor phosphorylation and uncoupling, may induce desensitization. These processes may contribute to complex intracellular regulatory processes and may be involved in some of the long-term effects of neurotransmitters (mainly neuropeptides and growth hormones) or drugs.

Changes in muscarinic acetylcholine receptors in the isolated duodenum from repeatedly cold-stressed rats and the effect of neurotropin

In rats repeatedly cold-stressed by specific alternation of rhythm in environmental temperature (SART-stressed rats), the contractile response to acetylcholine (ACh) of the isolated duodenum was remarkably decreased, whereas the contractile responses to K+, Ba2+ and Ca2+ were comparable to those in non-stressed rats. The amount of [3H]quinuclidinyl benzilate in the duodenum of SART-stressed rats was about 50% of that in non-stressed rats, but the KD value remained unchanged. Long-term administration of hexamethonium prevented the changes in SART-stressed rats. The daily treatment with Neurotropin, an extract isolated from inflamed rabbit dermis inoculated with vaccinia virus, dose-dependently prevented the changes in SART-stressed rats. However, Neurotropin had no effect on the ACh-induced decrease in muscarinic ACh receptor (m-ACh.R) in cultured vas deferens of guinea pig. These results suggest that down-regulation of m-ACh.R in duodenum by SART stress may be associated with enhanced activity in the parasympathetic center. Moreover, Neurotropin is thought to prevent the down-regulation of m-ACh.R throughout the central nervous system.

Temperature-dependence of desensitization induced by acetylcholine and histamine in guinea-pig ileal longitudinal muscle

1. The effects of temperature on the time course of desensitization induced by acetylcholine and histamine, and on the recovery from desensitization were studied in the longitudinal muscle of the guinea-pig ileum. 2. Self- and cross-desensitization produced by acetylcholine (10(-5) M) occurred rapidly in the first 10 min of exposure to the agonist, with the same time course and the same degree of desensitization over the temperature range of 11 degrees C to 31 degrees C. 3. Self-desensitization produced by histamine (10(-5) M) also occurred rapidly in the first 10 min of exposure to the agonist, and showed great temperature-dependence, especially at 11 degrees C and 21 degrees C, but scarcely occurred at 6 degrees C. 4. Cross-desensitization produced by histamine developed gradually with time and showed a moderate temperature-dependence between 11 degrees C and 31 degrees C, but scarcely occurred at 6 degrees C. 5. The recovery processes from desensitization showed marked temperature-dependence. Recovery was halted completely at 11 degrees C. 6. These studies suggest that acetylcholine-induced desensitization may be attributed to a single non-specific mechanism. Histamine-induced desensitization may be due to at least two mechanisms: it occurs in both a specific and non-specific manner. Each of these desensitizations can be characterized by its unique temperature-dependence.

Mechanism of agonist-induced down-regulation and subsequent recovery of muscarinic acetylcholine receptors in a clonal neuroblastoma x glioma hybrid cell line

The mechanisms of carbachol-induced muscarinic acetylcholine receptor (mAChR) down-regulation, and recovery following carbachol withdrawal, were studied in the neuroblastoma x glioma hybrid NG108-15 cell line by specific ligand binding assays. N-[3H]Methylscopolamine ([3H]NMS) and [3H]quinuclidinyl benzilate ([3H]QNB) were used as the ligands for the cell surface and total cellular mAChRs, respectively. Exposure of cells to 1 mM carbachol for 16 h decreased the specific binding of [3H]NMS and [3H]QNB by approximately 80%. Bacitracin (1-4 mg/ml) and methylamine (1-15 mM), inhibitors of transglutaminase and of endocytosis, prevented agonist-induced loss of surface mAChRs. Pretreatment of cells with the antimicrotubular agents nocodazole (0.1-10 microM) and colchicine (1-10 microM) prevented carbachol-induced loss of [3H]QNB binding, but not that of [3H]NMS binding. These results indicate that agonist-induced mAChR down-regulation occurs by endocytosis, followed by microtubular transport of receptors to their intracellular degradation sites. When carbachol was withdrawn from the culture medium following treatment of cells for 16 h, receptors recovered and were incorporated to the surface membrane. This recovery process was antagonized by monovalent ionophores monensin (0.1 microM) and nigericin (40 nM), which interfere with Golgi complex function. Receptor recovery was also prevented by the antimicrotubular agent nocodazole. Thus, recovery of receptors appears to be mediated via Golgi complex and microtubular transport to the surface membrane.

Agonist-induced muscarinic acetylcholine receptor down-regulation in intact rat brain cells

Intact brain cells were prepared by dissociating whole adult rat brains without the cerebellum using a sieving technique. It has been found that preincubation of these cells with the muscarinic acetylcholine receptor agonist, carbamylcholine, results in a significant reduction in the specific binding of [3H]N-methylscopolamine to the receptors after the agonist was washed away. This agonist-mediated receptor down-regulation increased with prolongation of the exposure period to the agonist, and a steady state was achieved after 3 h at 37 degrees C. This effect of agonist was concentration-dependent, reaching a 30-35% decline in subsequent ligand binding upon preincubation with 1 mM carbamylcholine for 3 h. Carbamylcholine-induced receptor down-regulation was not apparent when exposure to the agonist was performed at 15 degrees C. In addition, it was abolished when the receptors were blocked by atropine. The decline in [3H]N-methylscopolamine binding induced by agonist was reflected as a significant reduction in the receptor density with no change in receptor affinity, suggesting that 'true' receptor down-regulation takes place. Moreover, when the receptors were labeled with the lipophilic antagonist [3H]quinuclidinyl benzilate instead of the hydrophilic ligand [3H]N-methylscopolamine, the magnitude of the observed receptor down-regulation was significantly lower in case of the former than the latter. This suggests that exposure of intact brain cells to muscarinic agonists might induce a slight degree of accumulation of receptors in intracellular sites before the receptors are actually degraded. These results are discussed in relation to previous findings regarding muscarinic receptor regulation in clonal cell lines.

Alterations in muscarinic receptors of ventricular muscle in carbachol-induced short-term desensitization

The inhibitory action of a muscarinic agonist on the contractile response of cardiac muscle is transient due to short-term desensitization of muscarinic cholinergic receptors. Studies were made on the binding of the muscarinic antagonist L-[3H]-quinuclidinyl benzilate ([3H]QNB) to the muscarinic receptor in the membrane fraction of ventricular muscle of guinea pigs desensitized by perfusion with carbachol for 10 min. Desensitization did not change the maximum binding or equilibrium dissociation constant (Kd) of [3H]QNB, but shifted the inhibition curves of [3H]QNB binding by carbachol to the right both in the presence and absence of 5-guanylyl imidodiphosphate (GppNHp). Analysis of these inhibition curves with a multiple site model suggested that superhigh and high affinity agonist binding sites were converted to low affinity sites in the desensitized state. GppNHp has additive effects to the prior exposure to carbachol, suggesting a different site of action from short-term exposure of agonist. We conclude that agonist-induced short-term desensitization of the muscarinic receptor of ventricular muscle is caused by reduction in the affinity of the receptor for agonist without reduction in its amount or affinity for antagonist.

Participation of protein synthesis in development of supersensitivity in cultured rat vas deferens

Organ culture of rat vas deferens produced supersensitivity to norepinephrine and acetylcholine in contractile response without change in alpha 1-adrenergic and muscarinic acetylcholine receptors. The development of supersensitivity was inhibited by low temperature and protein synthesis inhibitors. However, protein synthesis inhibitor had no significant effect on the receptors. These findings suggested that the supersensitivity may be induced by synthesis of protein(s) which have a stimulatory effect in a process(es) after activation of receptor to contraction.

Recovery of the muscarinic cholinergic receptor from its down-regulation in cultured smooth muscle

The recovery of the muscarinic cholinergic receptor (mAChR) from its down-regulation by long-term exposure to ACh was investigated. This was done to obtain information about regulation of the mAChR. Exposure of guinea-pig vas deferens to 30 microM ACh for 24 h decreased the amount of mAChR to 30% of the initial level, as measured with L-[3H]quinuclidinyl benzilate (QNB). The amount of mAChR was restored to 190% of its prewithdrawal level within 48 h of removal of ACh, without change in the KD value for L-[3H]QNB. This restoration was entirely dependent on protein synthesis. The half-life of the receptor was calculated to be 69 h. The recovery of mAChR was blocked by treatment with antimicrotubular agents, carboxylic ionophores, or 5 mM EGTA, which affect membrane protein synthesis. However, cytochalasin B and cyclic nucleotide derivatives had no effect. These data indicate that the recovery of mAChR was due to new synthesis of mAChR. The findings suggested that microtubules and the Golgi apparatus were involved in the biosynthesis of mAChR and that extracellular Ca2+ was necessary for the synthesis. Unlike the case with nicotinic AChR, the synthesis did not seem to be increased by cAMP or high extracellular Ca2+.

Changes in density of muscarinic cholinergic receptor by adrenergic denervation with guanethidine

The effects of chronic adrenergic denervation with guanethidine on muscarinic cholinergic receptors (mAChR) were investigated by binding of L-3H-quinuclidinyl benzilate (3H-QNB). Guanethidine treatment decreased the amount of mAChR from 102 to 87 fmoles/mg protein in the heart and from 444 to 388 fmoles/mg protein in the small intestine, but increased it from 223 to 282 fmoles/mg protein in the vas deferens, without changes in its characteristics. These findings suggested that adrenergic innervation has different influences on the mAChR population in different tissues.

Inhibition of agonist-induced degradation of muscarinic cholinergic receptor by quinacrine and tetracaine--possible involvement of phospholipase A2 in receptor degradation

Muscarinic cholinergic receptors (mAChR) are degraded on the addition of agonists through energy- and temperature-dependent processes, probably with clustering and endocytosis. Pretreatment of guinea-pig vas deferens with 0.5 mM quinacrine or 5 mM tetracaine, phospholipase A2 (PLase A2) inhibitors, inhibited the ACh-induced degradation of mAChR in the smooth muscle and kept mAChR on the surface membrane, while cocaine and procaine were not effective. On pretreatment with quinacrine or tetracaine the PLase A2 activity in the smooth muscle decreased continuously during culture without change in the contractile response of the tissue. Pretreatment with cocaine and procaine which had no significant effect on the down regulation of mAChR did not inhibit PLase A2 activity. However, activation of PLase A2 by long-term culture of the muscle with ACh and formation of endogenous inhibitor of PLase A2 were not observed under our experimental conditions. The participation of PLase A2 in the agonist-induced degradation of mAChR is discussed in the light of these findings.

Mechanism of agonist-induced degradation of muscarinic cholinergic receptor in cultured vas deferens of guinea-pig

The mechanism of agonist-induced degradation of muscarinic cholinergic receptors (mAChRs) was examined by means of [3H]QNB binding by organ-cultured guinea-pig vas deferens. Long-term exposure to ACh decreased the surface mAChR. This so-called 'down regulation' of mAChR was significantly inhibited by anti-endocytotic drugs. Anti-microtubular agents also strongly inhibited the decrease of mAChR remaining on the cell surface. Ammonium chloride and protease inhibitors, which are known to inhibit lysosomal enzymes, had little effect on the decrease and no increase in intracellular mAChR could be detected under these conditions. Chloroquine blocked the decrease in mAChR remaining on the cell surface. Based on these findings, the involvement of clustering and endocytosis in mAChR degradation were considered as possibilities. Furthermore, contraction of the smooth muscle to ACh in long-term desensitization was also examined in relation to the number and nature of the receptors. When the muscles were cultured with ACh and chloroquine or vinblastine, there were indications that the surface mAChR and the contractile system were uncoupled.